Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219802 | 12521980 | 2 | F | 20160614 | 20160708 | 20160701 | 20160713 | EXP | CA-JNJFOC-20160627053 | JANSSEN | 39.00 | YR | A | F | Y | 0.00000 | 20160713 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125219802 | 12521980 | 1 | PS | DARUNAVIR | DARUNAVIR | 1 | Oral | N | 21976 | 800 | MG | TABLETS | QD | ||||||
| 125219802 | 12521980 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | TABLET | ||||||||
| 125219802 | 12521980 | 3 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | 0 | 100 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125219802 | 12521980 | 1 | HIV infection |
| 125219802 | 12521980 | 2 | HIV infection |
| 125219802 | 12521980 | 3 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125219802 | 12521980 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125219802 | 12521980 | Abortion spontaneous | |
| 125219802 | 12521980 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |